Inari Medical, Inc. Common Stock
NARI
NARI was delisted on the 18th of February, 2025.
243 hedge funds and large institutions have $2.25B invested in Inari Medical, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 75 increasing their positions, 88 reducing their positions, and 37 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
5% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 37
0% more funds holding
Funds holding: 243 → 243 (0)
13% less capital invested
Capital invested by funds: $2.58B → $2.25B (-$322M)
15% less repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 88
21% less call options, than puts
Call options by funds: $4.53M | Put options by funds: $5.71M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VPC
Vestal Point Capital
New York
|
+$57.6M |
| 2 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$41M |
| 3 |
AC
Armistice Capital
New York
|
+$39M |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$36.9M |
| 5 |
Jennison Associates
New York
|
+$29.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$32.4M |
| 2 |
Millennium Management
New York
|
-$22.7M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$21.6M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$19.9M |
| 5 |
PE
Point72 Europe
London,
United Kingdom
|
-$15.9M |
NARI Hedge Fund Activity: Q3 2024 in Review
243 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Inari Medical, Inc. Common Stock (NARI) for Q3 2024, worth a combined $2.25B — down 13% from $2.58B a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new NARI positions and 37 closed out — a net gain of 2 holders — while 75 added to existing stakes and 88 trimmed.
The largest buyer was Vestal Point Capital, adding an estimated $57.6M. The largest seller was Point72 Asset Management, cutting an estimated $32.4M.
- 243 institutional investors held Inari Medical, Inc. Common Stock (NARI) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $2.25B of Inari Medical, Inc. Common Stock stock for Q3 2024, down 13% quarter-over-quarter.
- 39 funds opened new Inari Medical, Inc. Common Stock positions in Q3 2024 and 37 closed out, a net change of +2 holders.
- The largest Inari Medical, Inc. Common Stock buyer in Q3 2024 was Vestal Point Capital, an estimated $57.6M added.
- The largest Inari Medical, Inc. Common Stock seller in Q3 2024 was Point72 Asset Management, an estimated $32.4M sold.
Based on aggregated 13F filings for Q3 2024.